Insider Trading Tracker: Live US Stock Disclosures & Insider Buying from Jul 07, 2026 to Jul 21, 2026

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 200 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Morgan Stanley Estimates Beat	Michael A. Pizzi	Head Technology & Operations	Sale of securities on an exchange or to another person at price $ 215.00 per share.	17 Jul 2026	17,064	128,870 (0%)	0%	215	3,668,760	Common Stock
Morgan Stanley Estimates Beat	Michael A. Pizzi	Head Technology & Operations	Sale of securities on an exchange or to another person at price $ 216.88 per share.	17 Jul 2026	7,101	121,769 (0%)	0%	216.9	1,540,065	Common Stock
Lovesac Co	Vineet Mehra	Director	Sale of securities on an exchange or to another person at price $ 18.38 per share.	17 Jul 2026	5,000	17,992 (0%)	0%	18.4	91,909	Common Stock, par value $0.00001
Elevance Health Falling Membership	Gail Koziara Boudreaux	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 368.25 per share.	17 Jul 2026	2,045	171,976 (0%)	0%	368.2	753,071	Common Stock
Elevance Health Falling Membership	Ramiro G. Peru	Director	Purchase of securities on an exchange or from another person at price $ 366.05 per share.	17 Jul 2026	1,000	10,908 (0%)	0%	366.1	366,050	Common Stock
Elevance Health Falling Membership	Gail Koziara Boudreaux	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 366.41 per share.	17 Jul 2026	680	169,931 (0%)	0%	366.4	249,159	Common Stock
Community Trust Bancorp Inc	Kevin J. Stumbo	EVP, CFO, & Treasurer	Gift of securities by or to the insider at price $ 74.82 per share.	17 Jul 2026	50	6,998 (0%)	0%	74.8	3,741	Common Stock
Greenland Mines High Loss High Volume	Jeffrey Brian LeBlanc	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.18 per share.	16 Jul 2026	1,400,000	4,820,342	-	0.2	245,280	Common Stock
Elicio Therapeutics Inc	Robert Connelly	Director, CEO, President and Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	186,944	186,944	-		-	Stock Option (Right to Buy)
Caredx Inc	John Walter Hanna	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.20 per share.	16 Jul 2026	118,000	771,448 (1%)	0%	8.2	967,600	Common Stock
Caredx Inc	John Walter Hanna	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	118,000	512,706	-		-	Employee Stock Option (Right to Buy)
Caredx Inc	John Walter Hanna	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 39.01 per share.	16 Jul 2026	68,000	653,448 (1%)	0%	39.0	2,652,932	Common Stock
Elicio Therapeutics Inc	Christopher Haqq	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	64,643	64,643	-		-	Stock Option (Right to Buy)
Elicio Therapeutics Inc	Preetam Shah	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	60,833	60,833	-		-	Stock Option (Right to Buy)
W & T Offshore Inc	Daniel O. Conwill	Director	Sale of securities on an exchange or to another person at price $ 3.41 per share.	16 Jul 2026	60,000	191,076 (0%)	0%	3.4	204,600	Common Stock
Elicio Therapeutics Inc	Peter DeMuth	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	52,832	52,832	-		-	Stock Option (Right to Buy)
Caredx Inc	John Walter Hanna	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 36.11 per share.	16 Jul 2026	50,000	721,448 (1%)	0%	36.1	1,805,705	Common Stock
Caredx Inc	Hannah A. Valantine	Director	Sale of securities on an exchange or to another person at price $ 36.14 per share.	16 Jul 2026	28,679	36,786 (0%)	0%	36.1	1,036,588	Common Stock
Bank of New York Mellon	Robin A. Vince	Director, Chairman & CEO	Other type of transaction at price $ 161.07 per share.	16 Jul 2026	24,833	24,833 (0%)	0%	161.1	3,999,975	Common Stock
Bank of New York Mellon	Robin A. Vince	Director, Chairman & CEO	Other type of transaction at price $ 161.07 per share.	16 Jul 2026	24,833	625,794 (0%)	0%	161.1	3,999,975	Common Stock
Torrid Holdings Inc	Chinwe Abaelu	See Remarks	Sale of securities on an exchange or to another person at price $ 2.16 per share.	16 Jul 2026	24,401	202,461	-	2.2	52,706	Common Stock
Vaxcyte Inc	John H. Markels	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	23,029	23,029	-		-	Stock Option (right to buy)
Aehr Test Systems	Geoffrey G. Scott	Director	Sale of securities on an exchange or to another person at price $ 82.13 per share.	16 Jul 2026	20,000	30,000 (0%)	0%	82.1	1,642,650	Common Stock
Caredx Inc	Hannah A. Valantine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.19 per share.	16 Jul 2026	16,048	60,340 (0%)	0%	14.2	227,721	Common Stock
Caredx Inc	Hannah A. Valantine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	16,048	0	-		-	Stock Option (Right to Buy)
InnovAge Holding Corp	Patrick Blair	CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.87 per share.	16 Jul 2026	14,453	672,650	-	11.9	171,557	Common Stock, $0.001 par value
Corebridge Fin Inc Board Meeting	David Ditillo	Chief Information Officer	Sale of securities on an exchange or to another person at price $ 32.00 per share.	16 Jul 2026	12,414	119,653	-	32	397,248	Common Stock
Aehr Test Systems	Geoffrey G. Scott	Director	Gift of securities by or to the insider at price $ 0.00 per share.	16 Jul 2026	10,000	30,686 (0%)	0%		0	Common Stock
First Interstate BancSystem Inc Results Board Meeting	Jonathan R. Scott	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 40.30 per share.	16 Jul 2026	10,000	842,738 (1%)	0%	40.3	403,000	Common Stock
Monte Rosa Therapeutics Inc	Markus Warmuth	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 23.18 per share.	16 Jul 2026	9,500	585,038	-	23.2	220,219	Common Stock
Morgan Stanley Estimates Beat	Sharon Yeshaya	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 222.51 per share.	16 Jul 2026	9,172	0 (0%)	0%	222.5	2,040,862	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share.	16 Jul 2026	8,300	53,472 (0%)	0%	146.0	1,212,049	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	8,300	80,740	-		-	Stock Option
Caredx Inc	Hannah A. Valantine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.56 per share.	16 Jul 2026	7,606	44,292 (0%)	0%	20.6	156,379	Common Stock
Caredx Inc	Hannah A. Valantine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	7,606	0	-		-	Stock Option (Right to Buy)
Morgan Stanley Estimates Beat	Sharon Yeshaya	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 222.51 per share.	16 Jul 2026	6,382	136,809 (0%)	0%	222.5	1,420,059	Common Stock
Caredx Inc	Hannah A. Valantine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.96 per share.	16 Jul 2026	5,125	65,465 (0%)	0%	8.0	40,795	Common Stock
Caredx Inc	Hannah A. Valantine	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	5,125	24,011	-		-	Stock Option (Right to Buy)
Corebridge Fin Inc Board Meeting	David Ditillo	Chief Information Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	3,914	22,828	-		-	Options (Rights to Buy)
Corebridge Fin Inc Board Meeting	David Ditillo	Chief Information Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.30 per share.	16 Jul 2026	3,914	132,067	-	20.3	79,454	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 534.21 per share.	16 Jul 2026	3,279	47,812 (0%)	0%	534.2	1,751,679	Common Stock
Ennis Inc	Alejandro Quiroz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	2,661	17,020 (0%)	0%		0	Common Stock
Ennis Inc	Troy L. Priddy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	2,661	25,825 (0%)	0%		0	Common Stock
Ennis Inc	Gary S. Mozina	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	2,661	23,531 (0%)	0%		0	Common Stock
Ennis Inc	Barbara T. Clemens	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	2,661	26,531 (0%)	0%		0	Common Stock
Ennis Inc	Aaron Carter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	2,661	21,046 (0%)	0%		0	Common Stock
Ennis Inc	Margaret A. Walters	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	2,661	18,141 (0%)	0%		0	Common Stock
Ennis Inc	Walter D. Gruenes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	2,661	13,404 (0%)	0%		0	Common Stock
Korn Ferry	Lesley Uren	CEO of Consulting	Sale of securities on an exchange or to another person at price $ 78.75 per share.	16 Jul 2026	2,000	30,109 (0%)	0%	78.8	157,500	Common Stock, par value $0.01 per share
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 534.99 per share.	16 Jul 2026	1,519	45,252 (0%)	0%	535.0	812,648	Common Stock
Academy Sports and Outdoors Inc	Jeffrey C. Tweedy	Director	Sale of securities on an exchange or to another person at price $ 48.00 per share.	16 Jul 2026	1,200	10,567	-	48	57,600	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 535.88 per share.	16 Jul 2026	1,041	46,771 (0%)	0%	535.9	557,851	Common Stock
Torrid Holdings Inc	Chinwe Abaelu	See Remarks	Sale of securities on an exchange or to another person at price $ 2.29 per share.	16 Jul 2026	1,000	201,461	-	2.3	2,290	Common Stock
Ennis Inc	Michael D. Magill	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	887	13,720 (0%)	0%		0	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 531.97 per share.	16 Jul 2026	861	51,891 (0%)	0%	532.0	458,025	Common Stock
Rockwell	Terry L. Riesterer	Vice President and Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	849	850	-		-	Restricted Stock Units
Rockwell	Terry L. Riesterer	Vice President and Controller	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	16 Jul 2026	849	1,883 (0%)	0%		0	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 532.94 per share.	16 Jul 2026	800	51,091 (0%)	0%	532.9	426,352	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 527.60 per share.	16 Jul 2026	600	52,872 (0%)	0%	527.6	316,557	Common Stock
Smartstop Self Storage REIT Inc	David J. Mueller	Director	Sale of securities on an exchange or to another person at price $ 33.38 per share.	16 Jul 2026	425	5,065	-	33.4	14,187	Common Stock
German American Bancorp Inc	Zachary W. Bawel	Director	Purchase of securities on an exchange or from another person at price $ 47.85 per share.	16 Jul 2026	418	26,274 (0%)	0%	47.8	20,000	Common Stock
German American Bancorp Inc	Jason M. Kelly	Director	Purchase of securities on an exchange or from another person at price $ 47.85 per share.	16 Jul 2026	418	15,506 (0%)	0%	47.8	20,000	Common Stock
German American Bancorp Inc	Christina M. Ryan	Director	Purchase of securities on an exchange or from another person at price $ 47.85 per share.	16 Jul 2026	418	19,105 (0%)	0%	47.8	20,000	Common Stock
German American Bancorp Inc	Andrew M. Seger	Director	Purchase of securities on an exchange or from another person at price $ 47.85 per share.	16 Jul 2026	418	19,992 (0%)	0%	47.8	20,000	Common
German American Bancorp Inc	Ronnie R. Stokes	Director	Purchase of securities on an exchange or from another person at price $ 47.92 per share.	16 Jul 2026	313	8,626 (0%)	0%	47.9	15,000	Common
Rockwell	Terry L. Riesterer	Vice President and Controller	Sale of securities on an exchange or to another person at price $ 453.23 per share.	16 Jul 2026	281	1,602 (0%)	0%	453.2	127,359	Common Stock
Forbright Inc Ordinary	Steven M. Shafran	Director	Grant, award, or other acquisition of securities at price $ 18.68 per share.	16 Jul 2026	235	6,441	-	18.7	4,390	Class A Common Stock
Aptargroup Inc	Candace S. Matthews	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	226	8,101 (0%)	0%		0	Common Stock
Forbright Inc Ordinary	Cynthia A. Flanders	Director	Grant, award, or other acquisition of securities at price $ 18.68 per share.	16 Jul 2026	220	20,241	-	18.7	4,110	Class A Common Stock
Verizon Communincations Results Board Meeting	Daniel H. Schulman	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	212	8,515	-		-	Phantom Stock (unitized)
Ventas	Matthew J. Lustig	Director	Grant, award, or other acquisition of securities at price $ 95.34 per share.	16 Jul 2026	209	95,663 (0%)	0%	95.3	19,927	Common Stock
Forbright Inc Ordinary	Jason M. Fish	Director	Grant, award, or other acquisition of securities at price $ 18.68 per share.	16 Jul 2026	205	6,376	-	18.7	3,829	Class A Common Stock
FMC Corp	K'Lynne Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	184	44,535 (0%)	0%		0	Common Stock
Ventas	Roxanne M. Martino	Director	Grant, award, or other acquisition of securities at price $ 95.53 per share.	16 Jul 2026	173	66,845 (0%)	0%	95.5	16,526	Common Stock
TotalEnergies SE (ADR) Results Board Meeting	Valerie Della Puppa Tibi	Non-Executive Director	Purchase of securities on an exchange or from another person at price $ 70.09 per share.	16 Jul 2026	156	505 (0%)	0%	70.1	10,934	Ords 2.50p
Aptargroup Inc	B. Craig Owens	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	11,233 (0%)	0%		0	Common Stock
Aptargroup Inc	George L. Fotiades	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	6,446 (0%)	0%		0	Common Stock
Aptargroup Inc	Ralf K. Wunderlich	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	18,690 (0%)	0%		0	Common Stock
Aptargroup Inc	Isabel Marey-Semper	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	9,821 (0%)	0%		0	Common Stock
Aptargroup Inc	Giovanna Kampouri Monnas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	10,128 (0%)	0%		0	Common Stock
Aptargroup Inc	Matthew L. Trerotola	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	9,306 (0%)	0%		0	Common Stock
Aptargroup Inc	Sarah Glickman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	4,553 (0%)	0%		0	Common Stock
Aptargroup Inc	Julie Xing	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	151	5,242 (0%)	0%		0	Common Stock
Verizon Communincations Results Board Meeting	Anthony T. Skiadas	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	138	144,469	-		-	Phantom Stock (unitized)
Verizon Communincations Results Board Meeting	Kyle Malady	EVP and Group CEO-VZ Business	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	138	417,694	-		-	Phantom Stock (unitized)
FMC Corp	Eduardo E. Cordeiro	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	131	41,011 (0%)	0%		0	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 529.81 per share.	16 Jul 2026	120	52,752 (0%)	0%	529.8	63,577	Common Stock
TotalEnergies SE (ADR) Results Board Meeting	Valerie Della Puppa Tibi	Non-Executive Director	Sale of securities on an exchange or to another person at price $ 95.89 per share.	16 Jul 2026	114	391 (0%)	0%	95.9	10,932	Ords 2.50p
TotalEnergies SE (ADR) Results Board Meeting	Romain Garcia-Ivaldi	Non-Executive Director	Sale of securities on an exchange or to another person at price $ 62.40 per share.	16 Jul 2026	114	687 (0%)	0%	62.4	7,114	Ords 2.50p
TotalEnergies SE (ADR) Results Board Meeting	Angel Pobo	Non-Executive Director	Sale of securities on an exchange or to another person at price $ 68.64 per share.	16 Jul 2026	114	1,491 (0%)	0%	68.6	7,825	Ords 2.50p
TotalEnergies SE (ADR) Results Board Meeting	Angel Pobo	Non-Executive Director	Purchase of securities on an exchange or from another person at price $ 70.09 per share.	16 Jul 2026	112	1,605 (0%)	0%	70.1	7,850	Ords 2.50p
York Water Co.	Joseph T. Hand	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 29.28 per share.	16 Jul 2026	111	43,307 (0%)	0%	29.3	3,250	Common Stock
York Water Co.	Matthew J. Scarpato	Chief Operating Officer	Purchase of securities on an exchange or from another person at price $ 29.28 per share.	16 Jul 2026	111	2,696 (0%)	0%	29.3	3,250	Common Stock
TotalEnergies SE (ADR) Results Board Meeting	Romain Garcia-Ivaldi	Non-Executive Director	Purchase of securities on an exchange or from another person at price $ 70.09 per share.	16 Jul 2026	102	801 (0%)	0%	70.1	7,149	Ords 2.50p
FMC Corp	Kathy Lynn Fortmann	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	101	23,653 (0%)	0%		0	Common Stock
Verizon Communincations Results Board Meeting	Vandana Venkatesh	EVP and Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	101	56,809	-		-	Phantom Stock (unitized)
Caredx Inc	Hannah A. Valantine	Director	Sale of securities on an exchange or to another person at price $ 36.55 per share.	16 Jul 2026	100	36,686 (0%)	0%	36.6	3,655	Common Stock
Verizon Communincations Results Board Meeting	Joseph J. Russo	EVP&Pres-Global Networks&Tech	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	88	83,397	-		-	Phantom Stock (unitized)
First Fin Corp - Indiana Results	James O. McDonald	Director	Purchase of securities on an exchange or from another person at price $ 75.30 per share.	16 Jul 2026	84	11,841 (0%)	0%	75.3	6,325	First Financial Corp Stock
FMC Corp	Carol Anthony Davidson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	83	32,574 (0%)	0%		0	Common Stock
Verizon Communincations Results Board Meeting	Rodriguez Alfonso Villanueva	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	83	6,659	-		-	Phantom Stock (unitized)
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale of securities on an exchange or to another person at price $ 536.85 per share.	16 Jul 2026	80	45,172 (0%)	0%	536.9	42,948	Common Stock
Ventas	Marguerite M. Nader	Director	Grant, award, or other acquisition of securities at price $ 95.86 per share.	16 Jul 2026	71	23,543 (0%)	0%	95.9	6,806	Common Stock
Ventas	Michael J. Embler	Director	Grant, award, or other acquisition of securities at price $ 95.86 per share.	16 Jul 2026	71	19,273 (0%)	0%	95.9	6,806	Common Stock
Ventas	Matthew J. Lustig	Director	Grant, award, or other acquisition of securities at price $ 95.86 per share.	16 Jul 2026	71	95,734 (0%)	0%	95.9	6,806	Common Stock
Ventas	Sumit Roy	Director	Grant, award, or other acquisition of securities at price $ 95.86 per share.	16 Jul 2026	71	24,871 (0%)	0%	95.9	6,806	Common Stock
Ventas	Melody C. Barnes	Director	Grant, award, or other acquisition of securities at price $ 95.86 per share.	16 Jul 2026	71	35,378 (0%)	0%	95.9	6,806	Common Stock
Ventas	Maurice S. Smith	Director	Grant, award, or other acquisition of securities at price $ 95.86 per share.	16 Jul 2026	71	31,311 (0%)	0%	95.9	6,806	Common Stock
Ventas	Maurice S. Smith	Director	Grant, award, or other acquisition of securities at price $ 95.38 per share.	16 Jul 2026	56	31,239 (0%)	0%	95.4	5,341	Common Stock
FMC Corp	Patricia D. Verduin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	50	16,376 (0%)	0%		0	Common Stock
FMC Corp	John M. Raines	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	48	23,044 (0%)	0%		0	Common Stock
Ventas	Joe V. Rodriguez	Director	Grant, award, or other acquisition of securities at price $ 96.06 per share.	16 Jul 2026	48	9,943 (0%)	0%	96.1	4,611	Common Stock
Ventas	Sumit Roy	Director	Grant, award, or other acquisition of securities at price $ 95.21 per share.	16 Jul 2026	47	24,799 (0%)	0%	95.2	4,475	Common Stock
Verizon Communincations Results Board Meeting	Mary-Lee Stillwell	SVP and Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	46	16,727	-		-	Phantom Stock (unitized)
FMC Corp	Pierre R. Brondeau	Director, Chairman, CEO and President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	44	533,913 (0%)	0%		0	Common Stock
York Water Co.	Alexandra C. Chiaruttini	CAO & General Counsel	Purchase of securities on an exchange or from another person at price $ 29.55 per share.	16 Jul 2026	44	5,929 (0%)	0%	29.5	1,300	Common Stock
York Water Co.	Suzanne M. Becker	VP- Customer Service	Purchase of securities on an exchange or from another person at price $ 29.55 per share.	16 Jul 2026	44	374 (0%)	0%	29.5	1,300	Common Stock
FMC Corp	Steven T. Merkt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	41	15,094 (0%)	0%		0	Common Stock
FMC Corp	Michael F. Barry	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jul 2026	11	28,820 (0%)	0%		0	Common Stock
York Water Co.	Mark S Snyder	VP- Engineering	Purchase of securities on an exchange or from another person at price $ 29.55 per share.	16 Jul 2026	11	4,930 (0%)	0%	29.5	325	Common Stock
Isabella Bank Corp Results	Jill Bourland	Director	Purchase of securities on an exchange or from another person at price $ 42.86 per share.	16 Jul 2026	7	5,892	-	42.9	300	common
York Water Co.	Matthew E. Poff	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 32.50 per share.	16 Jul 2026	4	9,502 (0%)	0%	32.5	130	Common Stock
Catalyst Pharma Inc Board Meeting	Patrick J. McEnany	Director, Chairman of Board of Directors	Sale or transfer of securities back to the company at price $ 31.50 per share.	15 Jul 2026	4,171,559	0 (0%)	4%	31.5	131,404,109	Common Stock, par value $0.001 per share
Catalyst Pharma Inc Board Meeting	Richard J. Daly	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	1,365,319	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 31.50 per share.	15 Jul 2026	1,093,803	0 (0%)	1%	31.5	34,454,795	Common Stock, par value $0.001 per share
Nuvalent Inc (Class A)	James R. Porter	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	867,172	0	-		-	Stock Option (Right to Buy)
Vivani Medical Inc	Gregg G. Williams	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.26 per share.	15 Jul 2026	793,650	36,912,736	-	1.3	999,999	Common Stock
Catalyst Pharma Inc Board Meeting	Patrick J. McEnany	Director, Chairman of Board of Directors	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	740,000	0	-		-	Options to purchase common stock
NGL Energy Partners LP - Unit	H. Michael Krimbill	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	700,000	3,678,615 (2%)	0%		0	Common Units
NGL Energy Partners LP - Unit	Bradley P Cooper	CFO & EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	600,000	800,000 (0%)	0%		0	Common Units
Joby Aviation Inc	JoeBen Bevirt	Director, CEO and Chief Architect	Sale of securities on an exchange or to another person at price $ 7.75 per share.	15 Jul 2026	596,666	58,410,711	-	7.8	4,624,162	Common Stock
Venture Global Inc (Class A)	Keith Larson	General Counsel and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share.	15 Jul 2026	555,556	555,556	-	0.8	438,889	Class A Common Stock
Venture Global Inc (Class A)	Keith Larson	General Counsel and Secretary	Sale of securities on an exchange or to another person at price $ 12.93 per share.	15 Jul 2026	555,556	0	-	12.9	7,182,395	Class A Common Stock
Venture Global Inc (Class A)	Keith Larson	General Counsel and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	555,556	3,700,397	-		-	Stock Options
Venture Global Inc (Class A)	Keith Larson	General Counsel and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.79 per share.	15 Jul 2026	555,555	555,555	-	0.8	438,888	Class A Common Stock
Venture Global Inc (Class A)	Keith Larson	General Counsel and Secretary	Sale of securities on an exchange or to another person at price $ 12.91 per share.	15 Jul 2026	555,555	0	-	12.9	7,174,382	Class A Common Stock
Venture Global Inc (Class A)	Keith Larson	General Counsel and Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	555,555	3,144,842	-		-	Stock Options
Nuvalent Inc (Class A)	James R. Porter	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	508,942	0	-		-	Stock Option (Right to Buy)
Catalyst Pharma Inc Board Meeting	Donald A. Denkhaus	Director	Sale or transfer of securities back to the company at price $ 31.50 per share.	15 Jul 2026	498,773	0 (0%)	0%	31.5	15,711,350	Common Stock, par value $0.001 per share
Catalyst Pharma Inc Board Meeting	Richard J. Daly	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	491,160	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Patrick J. McEnany	Director, Chairman of Board of Directors	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	400,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	David S. Tierney	Director	Sale or transfer of securities back to the company at price $ 31.50 per share.	15 Jul 2026	383,314	0 (0%)	0%	31.5	12,074,391	Common Stock, par value $0.001 per share
Catalyst Pharma Inc Board Meeting	Richard J. Daly	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	381,948	0	-		-	Options to purchase common stock
QuidelOrtho Corporation	Micah Young	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	356,555	356,555	-		-	Restricted Stock Units
Nextdoor Holdings Inc (Class A)	Nirav Tolia	Director, CEO and President, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	313,126	2,129,168	-		0	Class A Common Stock
Nextdoor Holdings Inc (Class A)	Nirav Tolia	Director, CEO and President, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	313,126	2,191,884	-		-	Restricted Stock Units (RSU)
Nuvalent Inc (Class A)	Christopher D. Turner	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	303,105	0	-		-	Stock Option (Right to Buy)
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	275,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Patrick J. McEnany	Director, Chairman of Board of Directors	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	272,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Richard J. Daly	Director, President and CEO	Sale or transfer of securities back to the company at price $ 31.50 per share.	15 Jul 2026	271,266	0 (0%)	0%	31.5	8,544,879	Common Stock, par value $0.001 per share
Catalyst Pharma Inc Board Meeting	Patrick J. McEnany	Director, Chairman of Board of Directors	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	270,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	248,004	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Brian Elsbernd	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 31.50 per share.	15 Jul 2026	242,501	0 (0%)	0%	31.5	7,638,782	Common Stock, par value $0.001 per share
Catalyst Pharma Inc Board Meeting	Preethi Sundaram	Chief Strategy Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	225,000	0	-		-	Options to purchase common stock
Nuvalent Inc (Class A)	James R. Porter	Director, President and CEO		15 Jul 2026	203,529	0	-		-	Class A Common Stock
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	202,958	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Brian Elsbernd	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	200,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Carmen Jeffrey Del	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	200,000	0	-		-	Options to purchase common stock
Cohu Inc	Jeffrey D. Jones	Sr. VP Finance & CFO	Other type of transaction at price $ 0.00 per share.	15 Jul 2026	190,590	190,590 (0%)	0%		0	Common Stock (Indirect)
Cohu Inc	Jeffrey D. Jones	Sr. VP Finance & CFO	Other type of transaction at price $ 0.00 per share.	15 Jul 2026	190,590	153,202	-		0	Restricted Stock Units
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	185,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	180,000	0	-		-	Options to purchase common stock
Alignment Healthcare Inc	Dawn Maroney	President	Sale of securities on an exchange or to another person at price $ 20.83 per share.	15 Jul 2026	177,068	922,313	-	20.8	3,687,990	Common Stock
Catalyst Pharma Inc Board Meeting	Carmen Jeffrey Del	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	167,918	0	-		-	Options to purchase common stock
Nuvalent Inc (Class A)	James R. Porter	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	161,100	0	-		-	Stock Option (Right to Buy)
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	158,454	0	-		-	Options to purchase common stock
Alignment Healthcare Inc	Dawn Maroney	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jul 2026	152,068	0	-		-	Options (Right to Buy)
Alignment Healthcare Inc	Dawn Maroney	President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.06 per share.	15 Jul 2026	152,068	1,099,381	-	9.1	1,377,736	Common Stock
Celsius Holdings Inc	William H. Milmoe	Former 10% owner		15 Jul 2026	150,000	12,682,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	William H. Milmoe	Former 10% owner		15 Jul 2026	150,000	12,832,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	William H. Milmoe	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	William H. Milmoe	Former 10% owner		15 Jul 2026	150,000	12,532,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	Dean Desantis	Former 10% owner		15 Jul 2026	150,000	12,832,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	Dean Desantis	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	Dean Desantis	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	Dean Desantis	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	Dean Desantis	Former 10% owner		15 Jul 2026	150,000	12,532,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	Dean Desantis	Former 10% owner		15 Jul 2026	150,000	12,682,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	Deborah DeSantis	Former 10% owner		15 Jul 2026	150,000	12,682,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	Deborah DeSantis	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	Deborah DeSantis	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	Deborah DeSantis	Former 10% owner		15 Jul 2026	150,000	0	-		-	Variable Prepaid Forward Sale Contract (obligation to sell)
Celsius Holdings Inc	Deborah DeSantis	Former 10% owner		15 Jul 2026	150,000	12,532,396 (18%)	0%	46.3	6,937,905	Common Stock
Celsius Holdings Inc	Deborah DeSantis	Former 10% owner		15 Jul 2026	150,000	12,832,396 (18%)	0%	46.3	6,937,905	Common Stock
Catalyst Pharma Inc Board Meeting	Carmen Jeffrey Del	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	150,000	0	-		-	Options to purchase common stock
Red Cat Holdings Inc	Jeffrey M. Thompson	Director, Chairman of the Board, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 8.51 per share.	15 Jul 2026	150,000	12,762,202	-	8.5	1,276,500	Common Stock
Catalyst Pharma Inc Board Meeting	Brian Elsbernd	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	147,621	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Steven R. Miller	Chief Op. & Scientific Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	146,000	0	-		-	Options to purchase common stock
Nuvalent Inc (Class A)	Christopher D. Turner	Chief Medical Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	144,200	0	-		-	Stock Option (Right to Buy)
Catalyst Pharma Inc Board Meeting	Preethi Sundaram	Chief Strategy Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	143,193	0	-		-	Options to purchase common stock
Quanterix Corp	Jason F. Faessler	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2026	141,820	141,820	-		-	Restricted Stock Unit
Catalyst Pharma Inc Board Meeting	Carmen Jeffrey Del	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	137,553	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Preethi Sundaram	Chief Strategy Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	137,553	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Brian Elsbernd	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	135,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Carmen Jeffrey Del	Chief Commercial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	135,000	0	-		-	Options to purchase common stock
Catalyst Pharma Inc Board Meeting	Brian Elsbernd	Chief Legal Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	132,000	0	-		-	Options to purchase common stock
Nuvalent Inc (Class A)	Alexandra Balcom	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	131,637	0	-		-	Stock Option (Right to Buy)
Nuvalent Inc (Class A)	James R. Porter	Director, President and CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	15 Jul 2026	131,494	0	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made from Jul 07, 2026 to Jul 21, 2026

Monitor US insider transactions and discover insider buying and selling of stocks from Jul 07, 2026 to Jul 21, 2026.

The latest disclosure under SEC insider trading regulations was reported by Morgan Stanley., where the revocation of 17,064 Common Stock of common stock was executed at an average price of $215. This transaction was reported to the Securities and Exchange Commission on July 17, 2026.

Screeners based on Insider Trading parameters